RNS Number : 7982G
Alumasc Group PLC
08 November 2018
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a.
|
Name
|
Michael Leaf
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
Persons Discharging Managerial responsibility
|
|
b.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
The Alumasc Group plc
|
|
b.
|
LEI
|
2138002MV11VKZFJ4359
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a.
|
Description of the
Financial instrument, type
of instrument
Identification code
|
Ordinary 12.5p shares
GB0000280353
|
|
b.
|
Nature of the transaction
|
Exercise of nil cost options under The Alumasc Group plc Long Term Incentive Plan and sale of shares.
|
|
c.
|
Price(s) and volume(s)
|
Exercise of Long Term Incentive Plan awards (nil cost options)
|
PDMR
|
Price(s)
|
Volume(s)
|
|
Michael Leaf
|
n/a
|
23,166
|
Sale of shares
|
PDMR
|
Price(s)
|
Volume(s)
|
|
Michael Leaf
|
127.1p
|
23,166
|
|
|
d.
|
Aggregated information
· Aggregated volume
· Price
|
Exercise of Long Term Incentive Plan awards
23,166 Ordinary 12.5p shares acquired through the exercise of nil cost options
Sale of shares
23,166 Ordinary 12.5p shares sold at 127.1 pence per share
|
|
e.
|
Date of the transaction
|
2018-11-07
10:46 (UTC)
|
|
f.
|
Place of the transaction
|
London Stock Exchange, Main Market (XLON)
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHFSAFFAFASEEF